Welcome to the world of immunohistochemistry!
📞 800-8581156 📧 info@naim.com.cn
Menu
  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Close
分类
  • Consultation and Feedback
  • Hotspot Focus
  • Immunohistochemistry and Pathology
  • Immunohistochemistry Technology Exchange
  • Industry News
  • Maxxin Dynamics
  • Meeting Notice
  • News and Information
  • Public laboratory
  • Recommended List and Introduction of Newly Developed IHC
  • Service and Support
  • Uncategorized
Product Search
06 2 月

Proposed General Classification Framework for Squamous Cell Carcinoma

Continue reading
06 2 月

On the Road – The Treasure Island of Taiwan (Part One)

Continue reading
06 2 月

New Applications of Antibodies // The Use of HNF1β in Ovarian Tumors

Continue reading
06 2 月

The industry standard for Immunohistochemistry Kits, co-drafted by Maixin, will officially take effect on March 1st this year.

Continue reading
06 2 月

2013 Academic Annual Meeting of the Tumor Pathology Professional Committee of the Chinese Anti-Cancer Association

Continue reading
06 2 月

Immunohistochemical Differential Diagnosis Chart for Central Nervous System

Continue reading
06 2 月

Ruijin Hospital’s Special Pathology Team Announces Major Breakthrough in Severe COVID-19 Etiology Research

Continue reading
06 2 月

How to Use Anti-Shedding Agent

Continue reading
06 2 月

On my 25th birthday, we are grateful for your blessings.

Continue reading
06 2 月

MaxVisionTM 2/HRP Immunohistochemistry Staining Procedure

Continue reading
  • «
  • ‹
  • 30
  • 31
  • 32
  • 33
  • 34
  • ›
  • »

Copyright © 1993 - 2017 Fuzhou Maixin Biotechnology Development Co., Ltd. MinICP No. 05015562-1 | (Fujian) - Non-commercial - 2017-0010

  • Home
  • Product
  • Service and Support
    • Immunohistochemistry and Pathology
    • Immunohistochemistry Technology Exchange
    • Recommended List and Introduction of Newly Developed IHC
    • Public laboratory
    • Consultation and Feedback
  • News and Information
    • Hotspot Focus
    • Industry News
    • Maxxin Dynamics
    • Meeting Notice
  • Entering Maixin
    • Corporate Culture
    • Maisin Honors
    • Maixin Company Profile
    • Myriad Pathology Foundation Overview
  • Contact us
Sidebar